Terms: = Lung cancer AND USP8, FLJ34456, 9101, ENSG00000138592, KIAA0055, P40818, MGC129718, UBPY, HumORF8
23 results:
1. Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell lung cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing.
Abuhejail RM; Alzoman NZ; Darwish IA
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894533
[TBL] [Abstract] [Full Text] [Related]
2. Targeting usp8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT.
Tang J; Long G; Hu K; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
Adv Sci (Weinh); 2023 Nov; 10(33):e2302953. PubMed ID: 37867237
[TBL] [Abstract] [Full Text] [Related]
3. Targeting MET endocytosis or degradation to overcome HGF-induced gefitinib resistance in EGFR-sensitive mutant lung adenocarcinoma.
Jiao D; Chen Y; Liu X; Tang X; Chen J; Liu Y; Jiang C; Chen Q
Biochem Biophys Res Commun; 2023 Nov; 682():371-380. PubMed ID: 37844446
[TBL] [Abstract] [Full Text] [Related]
4. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib.
Zhou D; Xu Z; Huang Y; Wang H; Zhu X; Zhang W; Song W; Gao T; Liu T; Wang M; Shi L; Zhang N; Xiong B
Eur J Med Chem; 2023 Jun; 254():115369. PubMed ID: 37075624
[TBL] [Abstract] [Full Text] [Related]
5. The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT
Sun Q; Zhang J; Li X; Yang G; Cheng S; Guo D; Zhang Q; Sun F; Zhao F; Yang D; Wang S; Wang T; Liu S; Zou L; Zhang Y; Liu H
J Adv Res; 2022 Nov; 41():1-12. PubMed ID: 36328739
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of Potent OTUB1/usp8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell lung cancer.
Tan L; Shan H; Han C; Zhang Z; Shen J; Zhang X; Xiang H; Lu K; Qi C; Li Y; Zhuang G; Chen G; Tan L
J Med Chem; 2022 Oct; 65(20):13645-13659. PubMed ID: 36221183
[TBL] [Abstract] [Full Text] [Related]
7. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/usp8 axis.
Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
[TBL] [Abstract] [Full Text] [Related]
8. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
[TBL] [Abstract] [Full Text] [Related]
9. Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients.
Inoue M; Kusumoto H; Shiono H; Shintani Y; Ose N; Sakamaki Y; Okami J; Higashiyama M; Takeuchi Y
J Chemother; 2019 Oct; 31(6):343-348. PubMed ID: 31409216
[TBL] [Abstract] [Full Text] [Related]
10. High Expression of Ubiquitin-Specific Protease 8 (usp8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma.
Yan M; Zhao C; Wei N; Wu X; Cui J; Xing Y
Med Sci Monit; 2018 Jul; 24():4934-4943. PubMed ID: 30010158
[TBL] [Abstract] [Full Text] [Related]
11. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
[TBL] [Abstract] [Full Text] [Related]
12. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Husni RE; Sakashita S; Takeuchi T; Noguchi M
Pathol Int; 2017 Jun; 67(6):292-301. PubMed ID: 28544031
[TBL] [Abstract] [Full Text] [Related]
13. Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension.
Rengier F; Wörz S; Melzig C; Ley S; Fink C; Benjamin N; Partovi S; von Tengg-Kobligk H; Rohr K; Kauczor HU; Grünig E
PLoS One; 2016; 11(9):e0162516. PubMed ID: 27626802
[TBL] [Abstract] [Full Text] [Related]
14. The diagnostic value of tumor markers in bronchoalveolar lavage fluid for the peripheral pulmonary carcinoma.
Zhang S; Zhao YF; Zhang MZ; Wu XL
Clin Respir J; 2017 Jul; 11(4):481-488. PubMed ID: 26260621
[TBL] [Abstract] [Full Text] [Related]
15. Repeat cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent diffuse malignant peritoneal mesothelioma.
Huang Y; Alzahrani NA; Liauw W; Morris DL
Eur J Surg Oncol; 2015 Oct; 41(10):1373-8. PubMed ID: 26227745
[TBL] [Abstract] [Full Text] [Related]
16. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort.
Romon I; Rey G; Mandereau-Bruno L; Weill A; Jougla E; Eschwège E; Simon D; Druet C; Fagot-Campagna A
Diabet Med; 2014 Aug; 31(8):946-53. PubMed ID: 24627972
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and prognostic importance of XIAP and usp8 in advanced stages of non-small cell lung cancer.
Baykara M; Yaman M; Buyukberber S; Tufan G; Demirci U; Benekli M; Coskun U; Ozet A; Umit Bagriacik E
J BUON; 2013; 18(4):921-7. PubMed ID: 24344018
[TBL] [Abstract] [Full Text] [Related]
18. usp8 is a novel target for overcoming gefitinib resistance in lung cancer.
Byun S; Lee SY; Lee J; Jeong CH; Farrand L; Lim S; Reddy K; Kim JY; Lee MH; Lee HJ; Bode AM; Won Lee K; Dong Z
Clin Cancer Res; 2013 Jul; 19(14):3894-904. PubMed ID: 23748694
[TBL] [Abstract] [Full Text] [Related]
19. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
[TBL] [Abstract] [Full Text] [Related]
20. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
[TBL] [Abstract] [Full Text] [Related]
[Next]
